Clinical Utility of Home versus Hospital Spirometry in Fibrotic Interstitial Lung Disease: Evaluation after INJUSTIS Interim Analysis
Ann Am Thorac Soc
.
2022 Mar;19(3):506-509.
doi: 10.1513/AnnalsATS.202105-612RL.
Authors
Fasihul Khan
1
,
Lucy Howard
1
,
Glenn Hearson
1
,
Colin Edwards
2
,
Chris Barber
3
,
Steve Jones
4
,
Andrew M Wilson
5
,
Toby M Maher
6
,
Gauri Saini
1
,
Iain Stewart
7
,
Gisli Jenkins
7
Affiliations
1
Department of Respiratory Medicine, University of Nottingham Nottingham, United Kingdom.
2
patientMpower Ltd. Dublin, Ireland.
3
Sheffield Teaching Hospitals NHS Foundation Trust Sheffield, United Kingdom.
4
Action for Pulmonary Fibrosis Staffordshire, United Kingdom.
5
University of East Anglia Norwich, United Kingdom.
6
University of Southern California Los Angeles, California.
7
National Heart and Lung Institute, Imperial College London London, United Kingdom.
PMID:
34534053
DOI:
10.1513/AnnalsATS.202105-612RL
No abstract available
Publication types
Letter
MeSH terms
Hospitals
Humans
Lung
Lung Diseases, Interstitial* / diagnosis
Spirometry